wound treatment News
-
RevMedx receives CE Mark for XSTAT® injectable hemostatic devices
Revolutionary bleeding control technology will now be available in Europe and other International markets. RevMedx, Inc., a leader in innovative devices that control severe bleeding, today announced it has received CE (Conformité Européenne) Mark Certification for the XSTAT 30 and XSTAT 12 hemostatic devices in Europe. Unlike traditional wound treatments that may take several ...
By RevMedx
-
RevMedx announces adoption of XSTAT gunshot wound treatment by emergency responders in Highland Park, Texas
RevMedx, Inc. announced today that the Highland Park Department of Public Safety (Highland Park, TX) is fielding XSTAT as a new treatment option in their medical and trauma kits. Located three miles north of Dallas, Highland Park Department of Public Safety works closely with other Dallas Metro services including Dallas Fire and Rescue and University Park Fire Department on Automatic Assistance ...
By RevMedx
-
Next Science and 3M Donate $300,000 of Breakthrough Wound Treatment to Jacksonville-Area Charities
Next Science (ASX:NXS), an innovative medical technology company that is the leader in treating biofilm-based infections in humans, announced today that it has donated $300,000 worth of BlastX™ Antimicrobial Wound Gel to The Save A Leg, Save A Life Foundation in Ponte Vedra. The donation will support the foundation’s mission of reducing lower extremity amputations and improving wound ...
-
Endomedix Joins US Army Medical Research Groups in CRADA for Ocular Projectile Battlefield Trauma Project
Endomedix, Inc. announced today that it has entered into a Cooperative Research and Development Agreement or CRADA with the US. Army Institute of Surgical Research (USAISR) and the U.S. Army Medical Materiel Development Activity (USAMMDA). The CRADA will address a specific topic, “Ocular Projectile Battlefield Trauma Project”, an unsolved emergency medical treatment problem for ...
-
Healiva Acquires Two Wound-healing Cell Therapy Assets From Smith+Nephew
Healiva®, a patient-centric company delivering life-enhancing precision medicine for patients with chronic and acute wounds, announced today the acquisition of two innovative cell therapy assets from Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business. The acquisition enables Healiva® to establish one of the world’s broadest portfolios of affordable, ...
By healiva SA
-
RevMedx receives CE Mark for XGAUZE® self-expanding gauze.
Manufacturer of the revolutionary XSTAT technology will now have a second sterile wound dressing available in Europe and other International markets. RevMedx, Inc., a global leader in innovative devices that control severe bleeding, today announced it has received CE (Conformité Européenne) Mark Certification for the XGAUZE wound dressing in Europe. XGAUZE, a Class I sterile ...
By RevMedx
-
KitoTech Medical Launches microMend Skin Closure Variety Pack for Consumer Market
KitoTech Medical, a medical device company, announces the addition of the microMend® Variety Pack to its growing line of consumer skin closure products. The new product contains three different microMend Skin Closure device sizes, all designed for easy application by consumers. This unique product combination allows them to close most lacerations quickly and easily, whether at home or away. ...
-
How Small Adjustments to In-Office Dermatology Wound Care Can Affect the Bottom Line
The medical field uses advanced technology in all facets of daily operations. Patient intake forms, record keeping, communication portals, invoicing, and of course, procedures are enhanced by technological advances. Those advances are now shaping dermatology wound care too. Besides improved patient experience and clinical outcomes, technological advances can also positively affect a ...
-
Coloplast and the World Diabetes Foundation prevent amputations in India
Coloplast"s donation programme Access to Healthcare just signed a contract with the World Diabetes Foundation (WDF) about a new healthcare project in India. The project aims to improve the treatment of diabetic wounds. "Every single day, 110 Indians have a foot or part of their leg amputated due to diabetic foot ulcers, and an unknown number die before they are even diagnosed," says Per Ole ...
-
Evaluation of CO2 fractional laser beauty machine treatment effect
The most commonly used fractional laser is CO2 fractional laser beauty machine. After more than ten years of clinical application, it can be said that CO2 fractional laser skin resurfacing treatment technology is relatively safe. As long as its therapeutic energy and action density are mastered, there are generally no obvious side effects of. Bvlaser is a professional CO2 fractional laser ...
-
Expansion of Topical Wound Oxygen (TWO2) Product Family Extends Treatment to Chronic Wound Patients with Larger Limbs, Venous and Diabetic Foot Ulcers
AOTI Inc. announced today an eagerly anticipated expansion of its unique multi-modality Topical Wound Oxygen (TWO2) therapy product family. The addition of a new larger extremity-chamber to the company’s peripheral vascular disease (PVD) focused product line, allows for the application of TWO2 treatments for many more patients suffering from costly nonhealing chronic wounds. Especially ...
-
Takeover of terraplasma medical GmbH by the Viromed Group
The majority takeover of terraplasma medical GmbH by Viromed Plasma GmbH, a member of the Viromed Group, was announced today. terraplasma GmbH will continue to hold shares in terraplasma medical GmbH in order to contribute its expertise in the field of cold atmospheric plasmas in the future. The common goal of Viromed and terraplasma is to establish terraplasma medical as the world's leading ...
-
Microbion Corporation Announces Granting of a US Patent for a Pharmaceutical Composition of Pravibismane
Microbion Corporation today announced that the US Patent and Trademark Office (USPTO) issued to Microbion, United States Patent No. 11,324,715 on May 10, 2022, with claims to a pharmaceutical composition of pravibismane. The patent, titled “Bismuth-thiol compositions and methods for treating wounds,” adds to Microbion’s growing portfolio of intellectual property on the ...
-
Microbion Corporation today announced that the company will present a poster highlighting the in vitro activity of pravibismane against M. avium and M. abscessus non-tuberculous mycobacteria (NTM) at the Colorado Mycobacteria Conference 2022: Focus on NTM
Microbion Corporation today announced that the US Patent and Trademark Office (USPTO) issued United States Patent No. 11,207,288 to Microbion on December 28, 2021, with claims to the use of Microbion’s proprietary pravibismane topical composition for diabetic foot infections (“DFI”). The patent, entitled “Bismuth-thiol compositions and methods for treating wounds,” ...
-
DermBiont Announces Acquisition of SeylanMED to Expand its Portfolio of Targeted Topical Therapeutics Treating Skin Diseases at Their Root Cause
BOSTON, MA, October 21, 2020 – DermBiont, Inc., a clinical stage precision dermatology company targeting skin diseases at their root cause has expanded its pipeline and therapeutic modalities with the acquisition of SeylanMED, Inc. “This strategic acquisition delivers multi-factorial value,” said Karl Beutner, MD, PhD, Co-founder, CEO, and CMO of DermBiont. “It expands ...
-
TissueTech Announces Rebranding, Adopts BioTissue Name Across Entire Business
TissueTech, Inc.—a pioneer in the clinical application of cryopreserved human birth tissue products to treat ocular surface disease and disorders, chronic wounds, and musculoskeletal conditions—has unveiled a corporate rebranding, including a name change and a new logo. BioTissue, Inc. and Amniox Medical, Inc. will now both be known under a single commercial, customer facing entity, ...
-
SANUWAVE Health Presents dermaPACE System Treatment Study Results Showing Enhanced Localized Wound Tissue Oxygenation
SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for focused, shockwave systems in the non-medical field today presented results from a clinical case series that demonstrated improved wound healing when treated with its FDA-cleared, ...
-
Classification of Fractional Lasers
Fractional laser is a commonly used instrument in clinical beauty medicine. In addition to treating acne scars, burn scars, and trauma scars, it also has a good effect on facial rejuvenation, freckle removal, skin shrinking, and stretch marks. Bvlaser is a CO2 fractional laser machine factory supplier, we have best fractional laser machine for sale. What is fractional laser Fractional laser ...
-
Amniox Donates $10,000 to American Diabetes Association to Further Scientific Research into Treatment Options for Chronic Wounds
Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue products, announced today that it has gifted the American Diabetes Association (ADA) with a $10,000 donation to support scientific research and prediabetes education. Amniox has been a longtime proponent for the advancement of clinical research of this type. In November 2020, ...
-
Podimetrics Congratulates Department of Veterans Affairs Partner Suzanne Shirley on Winning the Service to the Citizen Award
VA Innovation Ecosystem leader recognized for the Initiative to End Diabetic Limb Loss. SOMERVILLE, Mass., June 29, 2021 — Podimetrics, a virtual care management company dedicated to preventing costly and deadly diabetic amputations, congratulates Suzanne Shirley today on winning the Service to Citizen Award in recognition for her leadership and dedication to the Veteran population ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you